000 | 01839 a2200589 4500 | ||
---|---|---|---|
005 | 20250513123959.0 | ||
264 | 0 | _c19971009 | |
008 | 199710s 0 0 eng d | ||
022 | _a0902-0063 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSingh, N | |
245 | 0 | 0 |
_aBloodstream infections in liver transplant recipients receiving tacrolimus. _h[electronic resource] |
260 |
_bClinical transplantation _cAug 1997 |
||
300 |
_a275-81 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAbdomen _xmicrobiology |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBacteremia _xetiology |
650 | 0 | 4 |
_aBiliary Tract _xmicrobiology |
650 | 0 | 4 |
_aCandidiasis _xetiology |
650 | 0 | 4 |
_aCatheterization, Peripheral _xadverse effects |
650 | 0 | 4 | _aCritical Care |
650 | 0 | 4 |
_aCryptococcosis _xetiology |
650 | 0 | 4 | _aEquipment Contamination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aForecasting |
650 | 0 | 4 |
_aFungemia _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
650 | 0 | 4 | _aLength of Stay |
650 | 0 | 4 |
_aLiver Abscess _xmicrobiology |
650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMethicillin Resistance |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPatient Readmission |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStaphylococcal Infections _xetiology |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aTacrolimus _xadverse effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUrinary Tract Infections _xmicrobiology |
700 | 1 | _aGayowski, T | |
700 | 1 | _aWagener, M M | |
700 | 1 | _aMarino, I R | |
773 | 0 |
_tClinical transplantation _gvol. 11 _gno. 4 _gp. 275-81 |
|
999 |
_c9247296 _d9247296 |